MoonLake Immunotherapeutics

NASDAQ:MLTX

Biotechnology

Healthcare
$10.79 +0.69%

+$0.13 today

Market cap
$918.30M
Beta
1.04
P/E (TTM)
-5.4
EPS (TTM)
-$3.61
52W Low $5.95High $62.75

Volume 1.32M

Average 0.99M

Balance Sheet

Inspect the capital base behind the business.

Assets

$424.43M

FY 2025 · Annual

-11.2% YoY

Liabilities

$119.95M

FY 2025 · Annual

+388.8% YoY

Equity

$304.48M

FY 2025 · Annual

-32.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents8.04M39.51M451.17M180.43M334.52M
Short-term Investments032.61M59.84M267.6M59.45M
Net Receivables148.77K217.13K1.06M2.84M4.87M
Inventory00000
Other Current Assets00000
Total Current Assets9.64M76.51M514.17M474.29M421.69M
Property, Plant & Equipment (Net)45.74K331.97K3.95M3.64M2.14M
Goodwill00000
Intangible Assets00000
Long-term Investments115.04M0000
Tax Assets00000
Other Non-current Assets(115.04M)(0)8.42M0596K
Total Non-current Assets45.74K331.97K12.37M3.64M2.74M
Total Assets9.68M76.84M526.54M477.93M424.43M
Account Payables1.23M47.48K1.46M8.68M0
Short-term Debt15M0001.23M
Tax Payables63.92K109.83K367.98K642.11K0
Deferred Revenue00000
Other Current Liabilities1.3M109.83K2.78M4.24M40.83M
Total Current Liabilities21.09M7.67M9.97M22.46M45.48M
Long-term Debt000074.47M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities239.86K282.21K583.43K620.68K(374K)
Total Non-current Liabilities239.86K411.16K3.08M2.08M74.47M
Total Liabilities21.33M8.08M13.05M24.54M119.95M
Common Stock38.54K5.27K6.3K6.39K7K
Retained Earnings(53.64M)(80.65M)(116.66M)(235.59M)(462.91M)
Accumulated OCI(168.18K)350.95K2.36M5M604K
Other Stockholders Equity00000
Minority Interest019.87M17.82M6.57M0
Total Equity(11.65M)68.77M513.49M453.39M304.48M
Total Debt15M282.58K3.7M2.83M75.71M
Net Debt6.96M(39.22M)(447.47M)(177.6M)(258.81M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$298.5M
Short-term Investments$59.4M
Receivables$5.8M
Other Current$33.0M
Total Current Assets$396.6M
PP&E (Net)$2.4M
Other Non-current$1.3M
Total Non-current Assets$3.7M
Total Assets$400.4M

Analysis

Selected assets total $400.4M for Latest. The largest visible component is Cash & Equivalents at $298.5M, about 74.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
8-KCurrent reportSep 30, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
SC 13GSC 13G filingAug 14, 2026

How much cash does MLTX have?

MoonLake Immunotherapeutics (MLTX) reported $334.52M in cash and equivalents in fiscal 2025.

How much debt does MLTX carry?

MoonLake Immunotherapeutics (MLTX) reported $75.71M of total debt, with net debt of -$258.81M.